胚系ATG2B/GSKIP 14q32重复易感早期克隆性造血并导致髓系肿瘤
研究分析6个家系中12例无症状携带者和52例18-74岁患者的41个髓系肿瘤常见突变基因测序,发现75%健康携带者存在早期克隆性造血且主要由TET2突变驱动,患者存在两条不同的克隆扩增和白血病发生路径,队列中完全缺乏DNMT3A突变。
要点
- 75%健康携带者存在早期克隆性造血,主要由TET2突变驱动。
- 第一条路径为MPN驱动事件伴TET2突变,早期发生MPN且10年后转化风险50%。
- 第二条路径无MPN驱动突变,直接导致无MPN前期的AML。
核心结论
- 胚系14q32重复可能通过促进TET2克隆性造血模拟造血衰老,从而易感髓系肿瘤。
- 患者存在两条不同的克隆扩增和白血病发生路径。
- 该队列中完全缺乏DNMT3A突变。
研究设计与样本
- 分析6个家系中12例无症状携带者和52例18-74岁患者。
- 对41个髓系恶性肿瘤常见突变基因进行靶向测序。
主要发现
- 75%的健康携带者显示早期克隆性造血,主要由TET2突变驱动。
- 第一条路径:MPN驱动事件伴半数病例TET2突变、三分之一病例剪接和/或RAS通路突变,早期发生MPN(主要为ET),10年后转化风险50%。
- 第二条路径:无MPN驱动突变,导致无MPN前期的AML,患者多具有继发于MDS的AML特异性基因组景观。
- 队列中完全缺乏DNMT3A突变。
临床怎么用
- 对14q32重复家系成员可考虑进行克隆性造血监测。
- 识别TET2突变驱动的早期克隆性造血有助于风险分层。
- 需警惕MPN转化及无MPN前期的AML发生。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The germline predisposition associated with the autosomal dominant inheritance of the 14q32 duplication implicating ATG2B/GSKIP genes is characterized by a wide clinical spectrum of myeloid neoplasms. We analyzed 12 asymptomatic carriers and 52 patients aged 18-74 years from six families, by targeted sequencing of 41 genes commonly mutated in myeloid malignancies. We found that 75% of healthy carriers displayed early clonal hematopoiesis mainly driven by TET2 mutations. Molecular landscapes of patients revealed two distinct routes of clonal expansion and leukemogenesis. The first route is characterized by the clonal dominance of myeloproliferative neoplasms (MPN)-driver events associated with TET2 mutations in half of cases and mutations affecting splicing and/or the RAS pathway in one-third of cases, leading to the early development of MPN, mostly essential thrombocythemia, with a high risk of transformation (50% after 10 years). The second route is distinguished by the absence of MPN-driver mutations and leads to AML without prior MPN. These patients mostly harbored a genomic landscape specific to acute myeloid leukemia secondary to myelodysplastic syndrome. An unexpected result was the total absence of DNMT3A mutations in this cohort. Our results suggest that the germline duplication constitutively mimics hematopoiesis aging by favoring TET2 clonal hematopoiesis.
引用
- Pegliasco J, Hirsch P, Marzac C, et al. Germline ATG2B/GSKIP-containing 14q32 duplication predisposes to early clonal hematopoiesis leading to myeloid neoplasms. Leukemia. 2021. PMID: 34172895. doi:10.1038/s41375-021-01319-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。